Machine learning-based histological classification that predicts recurrence of peripheral lung squamous cell
Yutaro Koike1, Keiju Aokage2, Kosuke Ikeda3
1Division of Pathology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
The stromal component ratio in lung squamous cell carcinoma (SqCC) predicts patient prognosis. A predominant stroma subtype indicates shorter recurrence-free survival (RFS), highlighting its role in malignant potential.
Area of Science:
- Oncology
- Computational Pathology
- Biostatistics
Background:
- Lung squamous cell carcinoma (SqCC) comprises cancer and stromal cells.
- Tumor microenvironment composition may influence patient outcomes.
Purpose of the Study:
- To investigate if the cancer cell to stromal component ratio predicts prognosis in SqCC patients.
- To utilize machine learning for objective component analysis and prognostic evaluation.
Main Methods:
- Machine learning was employed to quantify cancer cell, necrotic, and stromal components in 135 SqCC cases.
- Cases were classified into predominant cancer cell, necrosis, or stroma subtypes.
- Prognostic significance of subtypes was assessed, focusing on recurrence-free survival (RFS).
Main Results:
- The predominant stroma subtype (70 cases) showed significantly shorter 5-year RFS (42.3%) compared to the predominant cancer cell subtype (59 cases, 84.3%).
- This association remained significant in pathological stage I patients (5-year RFS: 64.3% vs. 88.4%).
- Multivariate analysis confirmed the predominant stroma subtype as an independent prognostic factor for RFS in stage I SqCC.
Conclusions:
- The predominant stroma subtype is an independent negative prognostic factor for RFS in SqCC.
- The ratio of stromal component correlates with the malignant potential of SqCC.
- Machine learning provides objective quantification for prognostic assessment in lung cancer.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
08:54Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
Published on: May 20, 2020
